Search for Clinical Trial Results

Sponsored By

Leukemia, Myelomonocytic, Juvenile - 25 Studies Found

Status Study
Recruiting Study Name: Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)
Condition: Juvenile Myelomonocytic Leukemia
Date: 2005-09-09
Interventions:
  • Biological: Stem Cell Transplant

Active, not recruiting Study Name: Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia
Condition: Juvenile Myelomonocytic Leukemia
Date: 2013-04-02
Interventions:
  • Procedure: Allogeneic Hematopoietic Stem Cell Transplantation

Completed Study Name: Combination Chemotherapy Followed By Donor Bone Marrow or Umbilical Cord Blood Transplant in Treating Children With Newly Diagnosed Juvenile Myelomonocytic Leukemia
Condition: Juvenile Myelomonocytic Leukemia
Date: 2001-10-11
Interventions:
  • Drug: tipifarnib Given orally
Recruiting Study Name: Study With Azacitidine in Pediatric Subjects With Newly Diagnosed Advanced Myelodysplastic Syndrome (MDS) and Juvenile Myelomonocytic Leukemia (JMML)
Condition:
  • Myelodysplastic Syndrome
  • Leukemia, Myelomonocytic, Juvenile Date: 2015-04-14
    Interventions: Drug: Azacitidine Other Name: Vidaza
Terminated Study Name: Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation
Condition: Leukemia
Date: 2008-02-06
Interventions:
  • Drug: cyclosporine Patients wi
Terminated Study Name: Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia
Condition: Leukemia
Date: 2007-07-27
Interventions: Drug: Etanercept 0.8 mg/kg Subcutaneously Once A Week for 90 Days
Active, not recruiting Study Name: Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk Leukemia
Condition:
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Date: 2009-11-23
    Interventions:
    • Drug: Fludarabine Conditioning
Terminated Study Name: Allogenic Stem Cell Transplantation in Patients With High Risk CD33+ AML/MDS/JMML
Condition:
  • Acute Myeloid Leukemia
  • Juvenile Myelomonocytic Leukemia
    • Date: 2008-04-29
    Interventions:
    • Drug: Gemtuzumab Ozogamicin Do
Recruiting Study Name: Study for Epidemiology and Characterization of Myelodysplastic Syndromes (MDS) and Juvenile Myelomonocytic Leucemia (JMML) in Childhood
Condition:
  • Myelodysplastic Syndromes
  • Juvenile Myelomonocytic Leukemia

    • Date: 2008-04-17
Not yet recruiting Study Name: Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT)
Condition:
  • Acute Leukemias
  • Chronic Leukemias
  • Myelodysplastic Syndrome
    Date: 2011-04-20
    Interventions: Drug: Busulfan/Cyclophosphamide Conditioning regimen:
Next >>>